These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36129525)

  • 1. γ-aminobutyric acid modulates α-cell hyperplasia but not β-cell regeneration induced by glucagon receptor antagonism in type 1 diabetic mice.
    Gu L; Cui X; Lin X; Yang J; Wei R; Hong T; Yang K
    Acta Diabetol; 2023 Jan; 60(1):19-28. PubMed ID: 36129525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic alpha cell glucagon-liver FGF21 axis regulates beta cell regeneration in a mouse model of type 2 diabetes.
    Cui X; Feng J; Wei T; Zhang L; Lang S; Yang K; Yang J; Liu J; Sterr M; Lickert H; Wei R; Hong T
    Diabetologia; 2023 Mar; 66(3):535-550. PubMed ID: 36331598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice.
    Wei T; Cui X; Jiang Y; Wang K; Wang D; Li F; Lin X; Gu L; Yang K; Yang J; Hong T; Wei R
    Diabetes; 2023 May; 72(5):599-610. PubMed ID: 36826938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Treatment with Empagliflozin and GABA Improves
    Daems C; Welsch S; Boughaleb H; Vanderroost J; Robert A; Sokal E; Lysy PA
    J Diabetes Res; 2019; 2019():2813489. PubMed ID: 31467926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.
    Wei R; Cui X; Feng J; Gu L; Lang S; Wei T; Yang J; Liu J; Le Y; Wang H; Yang K; Hong T
    Metabolism; 2020 Oct; 111():154324. PubMed ID: 32712220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-receptor-antagonism-mediated β-cell regeneration as an effective anti-diabetic therapy.
    Xi Y; Song B; Ngan I; Solloway MJ; Humphrey M; Wang Y; Mondal K; Wu H; Liu W; Lindhout DA; Li D; Matern H; Kekatpure A; Haldankar R; Kaplan DD; Yang H; Pedersen O; Chen A; Zhou M; Winans B; Guo W; Kutach A; Fanget M; Fox M; Tang J; Zha J; Younis H; Shen D; DePaoli A; Tian H; Liu Z
    Cell Rep; 2022 May; 39(9):110872. PubMed ID: 35649369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon receptor blockage inhibits β-cell dedifferentiation through FoxO1.
    Wang K; Cui X; Li F; Xia L; Wei T; Liu J; Fu W; Yang J; Hong T; Wei R
    Am J Physiol Endocrinol Metab; 2023 Jan; 324(1):E97-E113. PubMed ID: 36383639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracrine GABA and insulin regulate pancreatic alpha cell proliferation in a mouse model of type 1 diabetes.
    Feng AL; Xiang YY; Gui L; Kaltsidis G; Feng Q; Lu WY
    Diabetologia; 2017 Jun; 60(6):1033-1042. PubMed ID: 28280900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-α-cell-derived β-cells contribute to β-cell neogenesis induced by antagonistic glucagon receptor antibody in type 2 diabetic mice.
    Cui X; Feng J; Wei T; Gu L; Wang D; Lang S; Yang K; Yang J; Yan H; Wei R; Hong T
    iScience; 2022 Jul; 25(7):104567. PubMed ID: 35789836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonistic Glucagon Receptor Antibody Promotes α-Cell Proliferation and Increases β-Cell Mass in Diabetic Mice.
    Wei R; Gu L; Yang J; Yang K; Liu J; Le Y; Lang S; Wang H; Thai D; Yan H; Hong T
    iScience; 2019 Jun; 16():326-339. PubMed ID: 31203188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon receptor antagonism promotes the production of gut proglucagon-derived peptides in diabetic mice.
    Lang S; Wei R; Wei T; Gu L; Feng J; Yan H; Yang J; Hong T
    Peptides; 2020 Sep; 131():170349. PubMed ID: 32561493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia.
    Gu W; Yan H; Winters KA; Komorowski R; Vonderfecht S; Atangan L; Sivits G; Hill D; Yang J; Bi V; Shen Y; Hu S; Boone T; Lindberg RA; Véniant MM
    J Pharmacol Exp Ther; 2009 Dec; 331(3):871-81. PubMed ID: 19720878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of the glucagon receptor gene before and after experimental diabetes reveals differential protection from hyperglycemia.
    Rivero-Gutierrez B; Haller A; Holland J; Yates E; Khrisna R; Habegger K; Dimarchi R; D'Alessio D; Perez-Tilve D
    Mol Metab; 2018 Nov; 17():28-38. PubMed ID: 30170980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon receptor antagonism increases mouse pancreatic δ-cell mass through cell proliferation and duct-derived neogenesis.
    Gu L; Cui X; Lang S; Wang H; Hong T; Wei R
    Biochem Biophys Res Commun; 2019 May; 512(4):864-870. PubMed ID: 30929915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway.
    Wang MY; Yan H; Shi Z; Evans MR; Yu X; Lee Y; Chen S; Williams A; Philippe J; Roth MG; Unger RH
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2503-8. PubMed ID: 25675519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
    Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B
    Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon receptor antagonist upregulates circulating GLP-1 level by promoting intestinal L-cell proliferation and GLP-1 production in type 2 diabetes.
    Lang S; Yang J; Yang K; Gu L; Cui X; Wei T; Liu J; Le Y; Wang H; Wei R; Hong T
    BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32139602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of glucagon signaling prevents or reverses diabetes onset only if residual β-cells persist.
    Damond N; Thorel F; Moyers JS; Charron MJ; Vuguin PM; Powers AC; Herrera PL
    Elife; 2016 Apr; 5():. PubMed ID: 27092792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of GLP-1 Receptor Activation and Glucagon Blockage Promotes Pancreatic
    Gu L; Wang D; Cui X; Wei T; Yang K; Yang J; Wei R; Hong T
    J Diabetes Res; 2021; 2021():7765623. PubMed ID: 39280767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gimmicks of gamma-aminobutyric acid (GABA) in pancreatic β-cell regeneration through transdifferentiation of pancreatic α- to β-cells.
    Yi Z; Waseem Ghani M; Ghani H; Jiang W; Waseem Birmani M; Ye L; Bin L; Cun LG; Lilong A; Mei X
    Cell Biol Int; 2020 Apr; 44(4):926-936. PubMed ID: 31903671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.